Impact of Social Stress on TLR4-Induced Microbicidal Activity of CD11b+ Cells
社会压力对 TLR4 诱导的 CD11b 细胞杀菌活性的影响
基本信息
- 批准号:7473192
- 负责人:
- 金额:$ 7.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-01 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAnimalsApplications GrantsBacteriaBacterial InfectionsBehavioralBiological ModelsBloodBone MarrowC3H/HeJ MouseCell physiologyCellsCharacteristicsCircadian RhythmsCommunicable DiseasesComplexCorticosteroneDataDisruptionEscherichia coliExposure toFigs - dietaryFutureGlucocorticoidsGoalsHumanITGAM geneImmune responseImmune systemImmunityImmunosuppressionImmunosuppressive AgentsIn VitroInfectionInflammatoryInterleukin-6InvadedKnowledgeLifeLigationLipid ALipopolysaccharidesMAPK14 geneMAPK8 geneMicrobeMitogen-Activated Protein KinasesMitogensMusMyeloid CellsNatural ImmunityNitric OxideNumbersOrganismOutcomePathologyPersonal SatisfactionPhagocytesPhasePhysiologicalProductionProteinsPsychological StressPurposeResearchResistanceSignal TransductionSocial ChangeSpleenStimulusStressSurfaceTLR4 geneTestingThinkingToll-like receptorsTumor Necrosis Factor-alphaTumor Necrosis FactorsVirusbiological adaptation to stresscytokinedesignexperiencehuman TNF proteinimmune functionin vivoinsightinterdisciplinary approachkillingsmacrophagemicrobialmicrobicidemitogen-activated protein kinase p38novel therapeuticspathogenpathogenic bacteriareactive oxygen intermediateresponsesocialsocial stressstressortoll-like receptor 4trafficking
项目摘要
DESCRIPTION (provided by applicant): Psychological stress is often thought to be immunosuppressive, but it is now known that in some cases stress can enhance certain aspects of the immune response. Despite this knowledge, relatively few studies have focused on stress-induced immunoenhancement. Therefore, the overarching goal of this grant proposal is to identify how stress enhances innate resistance to infectious disease. Social stressors in mice involve physical interactions, making them unique from other types of stressors. The social stressor called social disruption (SDR) has the added characteristic of changing social order and dominance in group-living mice. We have determined that these interactions enhance certain aspects of the immune response. For example, SDR results in the trafficking of CD11b+ myeloid cells from the bone marrow to the spleen, where they are resistant to the suppressive effects of corticosterone and produce significantly higher levels of pro-inflammatory cytokines upon in vitro stimulation with the toll-like receptor (TLR) 4 agonists lipopolysaccharide and lipid A. SDR also increases the capacity of splenic CD11b+ macrophages to kill Escherichia coli in culture. This stress-induced enhancement was also evident in vivo; mice exposed to SDR prior to infection with E. coli cleared the bacteria from the blood and spleen more rapidly than did non-stressed control mice. Because signaling through TLR4 heavily influences the microbicidal activities of macrophages, and because the effects of SDR on CD11b+ cells are dependent upon TLR stimulation, this is an ideal model system to test the hypothesis that social stress enhances resistance to microbial infection by altering TLR4 functioning on CD11b+ cells. Three specific aims have been developed to: 1) test whether SDR enhances TLR4 expression and/or sensitivity on splenic CD11b+ cells, using microbicidal reactive oxygen intermediates (ROI) and nitric oxide (NO) as outcome variables, 2) examine whether this increased reactivity is dependent upon mitogen activated protein (MAP) kinases p38, JNK, and ERK1/2, which can enhance microbicidal activity 3) examine the importance of SDR-enhanced TLR4 and MAP kinase signaling for clearing a bacterial infection. This interdisciplinary approach will provide valuable insight into the complex host-pathogen relationship during quiescent and stressful periods. Defining the stress-induced cellular changes that enhance immune functioning could stimulate new therapeutic approaches to treating infectious diseases.
描述(由申请人提供):心理压力通常被认为具有免疫抑制作用,但现在已知,在某些情况下,压力可以增强免疫反应的某些方面。尽管有这些知识,相对较少的研究集中在应激诱导的免疫增强。因此,这项拨款提案的首要目标是确定压力如何增强对传染病的先天抵抗力。小鼠的社会压力源涉及身体互动,使其与其他类型的压力源不同。被称为社会破坏(SDR)的社会压力源具有改变群体生活小鼠的社会秩序和主导地位的额外特征。我们已经确定,这些相互作用增强了免疫反应的某些方面。例如,SDR导致CD 11b+骨髓细胞从骨髓运输至脾脏,在脾脏中,它们对皮质酮的抑制作用具有抗性,并且在用toll样受体(TLR)4激动剂脂多糖和脂质A体外刺激时产生显著更高水平的促炎细胞因子。SDR还增加脾CD 11b+巨噬细胞杀死培养物中大肠杆菌的能力。这种应激诱导的增强在体内也很明显;小鼠在感染E.大肠杆菌从血液和脾脏中清除细菌的速度比非应激对照组小鼠更快。由于通过TLR 4的信号传导严重影响巨噬细胞的杀微生物活性,并且由于SDR对CD 11b+细胞的作用依赖于TLR刺激,因此这是一个理想的模型系统,用于测试社会压力通过改变CD 11b+细胞上的TLR 4功能来增强对微生物感染的抵抗力的假设。制定了三个具体目标:1)使用杀微生物活性氧中间体(ROI)和一氧化氮(NO)作为结果变量,测试SDR是否增强脾CD 11b+细胞上的TLR 4表达和/或敏感性,2)检查这种增加的反应性是否依赖于促分裂原活化蛋白(MAP)激酶p38、JNK和ERK 1/2,3)检测SDR增强的TLR 4和MAP激酶信号传导对于清除细菌感染的重要性。这种跨学科的方法将提供有价值的洞察复杂的宿主-病原体的关系在静止和紧张时期。确定增强免疫功能的应激诱导的细胞变化可以刺激治疗传染病的新治疗方法。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL T BAILEY其他文献
MICHAEL T BAILEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL T BAILEY', 18)}}的其他基金
Age-Related Dysbiosis and Physical Resilience
与年龄相关的生态失调和身体弹性
- 批准号:
10229304 - 财政年份:2020
- 资助金额:
$ 7.36万 - 项目类别:
Tunable Native Probiotic Formulations for the Treatment of NEC.
用于治疗 NEC 的可调节天然益生菌制剂。
- 批准号:
9883801 - 财政年份:2017
- 资助金额:
$ 7.36万 - 项目类别:
Tunable Native Probiotic Formulations for the Treatment of NEC.
用于治疗 NEC 的可调节天然益生菌制剂。
- 批准号:
9463530 - 财政年份:2017
- 资助金额:
$ 7.36万 - 项目类别:
Tunable Native Probiotic Formulations for the Treatment of NEC.
用于治疗 NEC 的可调节天然益生菌制剂。
- 批准号:
9309341 - 财政年份:2017
- 资助金额:
$ 7.36万 - 项目类别:
The Role of the Intestinal Microbiome in Anxiety and Depression
肠道微生物组在焦虑和抑郁中的作用
- 批准号:
9566299 - 财政年份:2015
- 资助金额:
$ 7.36万 - 项目类别:
The Role of the Intestinal Microbiome in Anxiety and Depression
肠道微生物组在焦虑和抑郁中的作用
- 批准号:
9353536 - 财政年份:2015
- 资助金额:
$ 7.36万 - 项目类别:
Role of Commensal Microbiota in Stressor-Induced Immunomodulation
共生微生物群在应激源诱导的免疫调节中的作用
- 批准号:
8701731 - 财政年份:2014
- 资助金额:
$ 7.36万 - 项目类别:
Role of stress-induced reduction in Lactobacillus reuteri on colonic inflammation
应激诱导的罗伊氏乳杆菌减少对结肠炎症的作用
- 批准号:
8651429 - 财政年份:2012
- 资助金额:
$ 7.36万 - 项目类别:
Role of stress-induced reduction in Lactobacillus reuteri on colonic inflammation
应激诱导的罗伊氏乳杆菌减少对结肠炎症的作用
- 批准号:
8238503 - 财政年份:2012
- 资助金额:
$ 7.36万 - 项目类别:
Impact of Social Stress on TLR4-Induced Microbicidal Activity of CD11b+ Cells
社会压力对 TLR4 诱导的 CD11b 细胞杀菌活性的影响
- 批准号:
7193206 - 财政年份:2007
- 资助金额:
$ 7.36万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 7.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 7.36万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 7.36万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 7.36万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 7.36万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 7.36万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 7.36万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 7.36万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 7.36万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 7.36万 - 项目类别: